Submission Details
| 510(k) Number | K171537 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 25, 2017 |
| Decision Date | September 12, 2017 |
| Days to Decision | 110 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K171537 is an FDA 510(k) clearance for the CAPI 3 Hb A1c, a Hemoglobin A1c Test System (Class II — Special Controls, product code PDJ), submitted by Sebia (Norcross, US). The FDA issued a Cleared decision on September 12, 2017, 110 days after receiving the submission on May 25, 2017. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1373.
| 510(k) Number | K171537 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 25, 2017 |
| Decision Date | September 12, 2017 |
| Days to Decision | 110 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | PDJ — Hemoglobin A1c Test System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1373 |
| Definition | Quantitative Determination Of Hemoglobin A1c To Aid In The Diagnosis Of Diabetes. |